Lipid-Modifying Therapies and Stroke Prevention

被引：0
|
作者：
Daniel G. Hackam
Robert A. Hegele
机构：
[1] Western University,Division of Clinical Pharmacology, Department of Medicine, Schulich School of Medicine and Dentistry
[2] Western University,Department of Epidemiology and Biostatistics
[3] Western University,Department of Clinical Neurological Sciences
[4] Western University,Division of Endocrinology and Metabolism, Department of Medicine, Schulich School of Medicine and Dentistry
来源：
Current Neurology and Neuroscience Reports | 2022年 / 22卷
关键词：
Ischemic stroke; Hemorrhagic stroke; Low-density lipoprotein; Triglyceride; Statin; Proprotein convertase subtilisin/kexin type 9;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：375 / 382
页数：7
相关论文
共 50 条
  • [41] Trends in utilization of lipid-modifying drugs in European Countries
    Papaioannidou, P.
    Stergiopoulou, T.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S74 - S74
  • [42] Atorvastatin: An effective lipid-modifying agent in familial hypercholesterolemia
    Marais, AD
    Firth, JC
    Bateman, ME
    Byrnes, P
    Martens, C
    Mountney, J
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (08) : 1527 - 1531
  • [43] Use of Lipid-Modifying Agents for the Treatment of Glomerular Diseases
    Ge, Mengyuan
    Merscher, Sandra
    Fornoni, Alessia
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (08):
  • [44] Attainment of Goal and Normalized Lipid Levels With Lipid-Modifying Therapy in Malaysia
    Hsu, Tun-Ying
    Chirovsky, Diana
    Moy, Foong Ming
    Ambegaonkar, Baishali M.
    [J]. CLINICAL THERAPEUTICS, 2013, 35 (04) : 450 - 460
  • [45] Triglyceride levels, pancreatitis and choice of lipid-modifying therapy
    Preiss, David
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 7 (03) : 193 - 195
  • [46] Longitudinal study of lipid-modifying therapies on carotid atherosclerotic plaque morphology in vivo using magnetic resonance imaging
    Reilly, MP
    Wolf, R
    Mohler, E
    Wright, A
    Song, HK
    Wehrli, F
    Rader, DJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (2A): : 84E - 84E
  • [47] Association of genetically predicted lipid traits and lipid-modifying targets with heart failure
    Xiao, Jun
    Ji, Jianguang
    Zhang, Naiqi
    Yang, Xi
    Chen, Keyuan
    Chen, Liangwan
    Huang, Wuqing
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 30 (04) : 358 - 366
  • [48] Effects of blood lipids and lipid-modifying drugs on intracranial aneurysms
    Zhang, Baorui
    Dong, Siyuan
    Miao, Yan
    Song, Guangrong
    Yuan, Fei
    Liu, Lang
    Xia, Saide
    Qin, Yongkai
    Huo, Xiaochuan
    Wu, Zhongxue
    Miao, Zhongrong
    Mo, Dapeng
    Liu, Aihua
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (10) : 2967 - 2975
  • [49] Are the lipid-modifying effects of fibrates mediated by alterations in plasma lipid transfer activity?
    Lewis, Gary F.
    [J]. CLINICAL SCIENCE, 2006, 111 (03) : 185 - 187
  • [50] Lipids, lipases, and lipid-modifying enzymes in plant disease resistance
    Shah, J
    [J]. ANNUAL REVIEW OF PHYTOPATHOLOGY, 2005, 43 : 229 - 260
12345